CASTLE BIOSCIENCES, INC. Equity Securities, FV-NI, Unrealized Gain (Loss)
CASTLE BIOSCIENCES, INC. (CSTL) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of -$244.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-06-30 was -$244.00K, a 120.59% decline year-over-year.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-03-31 was $2.15M.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-12-31 was -$2.34M, a 521.44% decline year-over-year.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-09-30 was $3.56M.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2025 was $982.00K, a 76.94% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2024 was $555.00K.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2023 was $0.00.
- CASTLE BIOSCIENCES, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2022 was $0.00.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$244.00K 10-Q · filed 2026-07-30 | $1.91M 10-Q · filed 2026-07-30 | -$434.00K derived: sum of 3 quarters · filed 2026-07-30 | $3.13M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $2.15M 10-Q · filed 2026-05-06 | -$190.00K derived: sum of 2 quarters · filed 2026-05-06 | $3.37M derived: sum of 3 quarters · filed 2026-05-06 | $4.56M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.22M derived: sum of 2 quarters · filed 2026-02-26 | $2.41M derived: sum of 3 quarters · filed 2026-07-30 | $982.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.56M 10-Q · filed 2025-11-03 | $4.75M derived: sum of 2 quarters · filed 2026-07-30 | $3.32M 10-Q · filed 2025-11-03 | $3.88M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.19M 10-Q · filed 2026-07-30 | -$240.00K 10-Q · filed 2026-07-30 | $315.00K derived: sum of 3 quarters · filed 2026-07-30 | $315.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$1.43M 10-Q · filed 2026-05-06 | -$870.00K derived: sum of 2 quarters · filed 2026-05-06 | -$870.00K derived: sum of 3 quarters · filed 2026-05-06 | -$870.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $555.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $555.00K derived: sum of 2 quarters · filed 2026-02-26 | $555.00K derived: sum of 3 quarters · filed 2026-02-26 | $555.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |